Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
22 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
GENESYS EUROPE from Elsene, company number BE0524786034, closed financial year 2025 with a result of € -983 after tax. For that financial year GENESYS EUROPE recorded a gross margin of € -400 and equity of € 3,653. Compared with financial year 2024, the result moved from € -1,149 to € -983. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 3,653
▼ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -983
▲ 14 % less loss than in 2024
Profit after tax over the fiscal year.
€ 6,648
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2,547.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 864
▲ 86% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | - | - | - | € -400 | |
| Profit after taxes | € -552 | € -604 | € -1,149 | € -983 | ▲ € 166 |
| Equity | € 6,389 | € 5,786 | € 4,637 | € 3,653 | ▼ 21% |
| Total debts | € 1,709 | € 2,282 | € 3,371 | € 4,356 | ▲ 29% |
| Cash | € 6,761 | € 6,724 | € 6,664 | € 6,648 | |
| Retained profit | € 189 | € -414 | € -1,563 | € -2,547 | ▼ € 983 |
| Balance sheet total | € 8,098 | € 8,068 | € 8,008 | € 8,010 |
Key figures of GENESYS EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GENESYS EUROPE?
What happened at GENESYS EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 983. filed late Source: NBB ↗
- Patrick DE WOLF became a director. NBB
- Laetitia DE SMET became a director. NBB
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
From € 552 loss in 2022 to € 983 loss in 2025.
Management
Behind GENESYS EUROPE are Patrick DE WOLF and Laetitia DE SMET. Patrick DE WOLF is also behind FONDS SCIENTIFIQUE JEAN BASTIN. Laetitia DE SMET is also behind MEMOLUB INTERNATIONAL.
Directors
According to the 2025 annual accounts
since 2021
since 2021
Establishments
Establishment units
Physical locations of this company
Louizalaan 81 box 5
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 22 companies are registered at this address.
All companies at this address →LOUIS VUITTON BELGIUM
€ 59.5 million revenue · 2025
Invest Europe
€ 9.7 million revenue · 2025
DALDEWOLF
€ 1.2 million gross margin · 2025
DE WOLF PATRICK AVOCATS
€ 282,053 gross margin · 2025
WORLD CANCER RESEARCH FUND INTERNATIONAL I.A. - FONDS INTERNATIONAL DE LA RECHERCHE MONDIALE CONTRE LE CANCER
+17 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0524.786.034
- VAT number
- BE 0524.786.034
- Registered office
- Louizalaan 81 bus 5, 1050 Elsene
- Names & denominations
- GENESYS EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 2013
- Peppol
- Active · Active since 13 Oct 2026
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg